Other languages Marizyme, Inc.

Equities

GBSX

US5703721028

Delayed OTC Markets Other stock markets 02:09:19 2024-05-23 pm EDT			5-day change	1st Jan Change
0.093 ^USD	+74.48%		+16.25%	-7.09%

Feb. 06	Marizyme, Inc. Announces Resignation of Julie Kampf from the Board of Directors	CI
2023	Marizyme, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Marizyme, Inc. Announces Resignation of Julie Kampf from the Board of Directors	Feb. 06
Marizyme, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
Marizyme, Inc. Announces FDA Clearance for Product, Duragraft	23-10-06
Marizyme, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-18
Marizyme, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
Marizyme, Inc. Announces IP Developments for DuraGraft and its Pipeline of Products	23-05-10
Marizyme, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-24
Marizyme, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-24
Marizyme, Inc. Auditor Raises 'Going Concern' Doubt	23-03-23
Marizyme, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14
Marizyme, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15
Marizyme, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16
Marizyme, Inc. Appoints Michael R. Stewart to the Board, Effective June 1, 2022	22-05-12
Marizyme, Inc. Appoints Nilesh Patel to Board as Director	22-04-25
Marizyme, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-31
Marizyme, Inc. Auditor Raises 'Going Concern' Doubt	22-03-30
MMarizyme, Inc. Announces Allowance of Patent Application for Duragraft® by United States Patent and Trademark Office	22-01-05
Marizyme, Inc. Appoints David Barthel as Member of Board of Directors	21-12-23
Marizyme, Inc. completed the acquisition of My Health Logic Inc. from Health Logic Interactive Inc. (TSXV:CHIP.H).	21-12-21
Marizyme, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Marizyme, Inc.

Equities

GBSX

US5703721028

Other languages

Filters